0617

Welcome to the June issue! This month, our cover feature delves into the green rush of cannabinoids, and pharma’s fascination with creating medicines from the cannabis plant. In My View sees experts discuss explosive chemical reactions, extended ANDA approval times, and the upcoming serialization deadlines. We also investigate the story behind the world’s first JAK inhibitor for rheumatoid arthritis, how the trends in small-molecule drugs are affecting outsourcing, the importance of manufacturing strategies in bioprocessing, and what the UK’s Brexit decision means for pharmacovigilance. Plus, we sit down with Elisa Cascade, President of Data Solutions at DrugDev.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Business & Regulation Small Molecules

Bringing Down the House

06/21/2017 | Stephanie Vine

Is it a waste when manufacturers demolish facilities before they're even used?

Manufacture Technology and Equipment

CLOUD with a Silver Lining

06/21/2017 | William Aryitey

A new database hopes to be the perfect tool for finding new novel drug combinations

Manufacture Analytical Science

Nanofluidic PAT

06/21/2017 | William Aryitey

Real-time monitoring and analysis of biologics during manufacturing is within reach

Manufacture Technology and Equipment

Leidenfrost Nanochemistry

06/21/2017 | James Strachan

How volcanoes inspired the fabrication of nanoparticles for cancer treatment

Business & Regulation Business Practice

What Bad Rep?

06/21/2017 | James Strachan

Take a look at the Reputation Institute's ranking of the pharma industry

Business & Regulation Quality & Compliance

A Positive-Sum Game

06/21/2017 | James Strachan

How important is pharmacovigilance in the post-market safety of drugs?

Business & Regulation Business Practice

Business-in-Brief

06/21/2017 | William Aryitey

Free cancer drugs, mispackaged contraceptive pills, and antibiotic action… What's new for pharma in business?

Manufacture Business Practice

When Experiments Go Wrong

06/21/2017 | Carmen Nitsche

Sharing data about dangerous chemical reactions could boost laboratory safety

Business & Regulation Standards & Regulation

Calling for ANDA Action

06/21/2017 | Girish Malhotra

Drug costs could be lowered if review and approval processes were much faster

Business & Regulation Packaging

Serial Killer?

06/21/2017 | Jean-Marie Aulnette

Data management is a key factor for success with serialization

Manufacture Drug Delivery

Pharma’s Great Green Rush

06/21/2017 | Stephanie Vine, James Strachan

What's causing pharma's fascination with cannabinoids and cannabis?

Manufacture Small Molecules

A Career in Cannabinoids

06/21/2017 | Roger Pertwee

Roger Pertwee discusses his pioneering work into cannabis, cannabinoids and the endocannabinoid system

Discovery & Development Clinical Trials

Cannabis Complex

06/21/2017 | George E. Anastassov

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

Manufacture Business Practice

Smashing the Stigma with Science

06/21/2017 | Neil Mahapatra, Stephanie Vine

Neil Mahapatra gives the story behind a partnership with Oxford University to develop cannabinoid medicines

Discovery & Development Small Molecules

A View From the Biosynthetic Bridge

06/21/2017 | Jeff Korentur

What are biosynthetic cannabinoids? And what do they mean for pharma?

Manufacture Drug Delivery

Forming a Cannabis Society

06/22/2017 | Roger Pertwee

The International Cannabinoid Research Society was formed in the early 1990s – and continues to grow

Manufacture Clinical Trials

Enhancing Endocannabinoid Signaling

06/22/2017 | Alan Ezekowitz

Boosting the body's built-in cannabinoid signaling receptors

Manufacture Small Molecules

Embracing the Medical Potential of Cannabinoids

07/21/2017 | Neil Mahapatra

Initial research into the uses of medical cannabis suggests applications across a range of diseases, but research is needed to realize cannabis’ full medical potential.